ReviewClinical cardiology2017

PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payers.

Seth J Baum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.